Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-6138.41%
operating margin TTM
-4618.85%
revenue TTM
N/A
revenue per share TTM
0.02$
valuation ratios | |
|---|---|
| pe ratio | -0.71 |
| peg ratio | -0.01 |
| price to book ratio | -0.34 |
| price to sales ratio | 0.00 |
| enterprise value multiple | 1.02 |
| price fair value | -0.34 |
profitability ratios | |
|---|---|
| gross profit margin | 77.46% |
| operating profit margin | -4618.85% |
| pretax profit margin | -6138.41% |
| net profit margin | -6138.41% |
| return on assets | -162.99% |
| return on equity | 56.36% |
| return on capital employed | 36.02% |
liquidity ratio | |
|---|---|
| current ratio | 0.10 |
| quick ratio | 0.02 |
| cash ratio | 0.01 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 22,659.12 |
| operating cycle | 22,659.12 |
| days of payables outstanding | 30,526.93 |
| cash conversion cycle | -7,867.80 |
| receivables turnover | 0.00 |
| payables turnover | 0.01 |
| inventory turnover | 0.02 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.30 |
| debt equity ratio | -0.38 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.61 |
| interest coverage | 22.22 |
| cash flow to debt ratio | -1.18 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.88 |
| cash per share | 0.02 |
| operating cash flow per share | -0.88 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.18 |
| short term coverage ratios | -1.18 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Acer Therapeutics Inc. (NASDAQ:ACER) reported earnings?
Acer Therapeutics Inc. (ACER) published its most recent earnings results on 20-11-2023.
What is Acer Therapeutics Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Acer Therapeutics Inc. (NASDAQ:ACER)'s trailing twelve months ROE is 56.36%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Acer Therapeutics Inc. (ACER) currently has a ROA of -162.99%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ACER's net profit margin stand at?
ACER reported a profit margin of -6138.41% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ACER's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.10 in the most recent quarter. The quick ratio stood at 0.02, with a Debt/Eq ratio of -0.38.